Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reiko Nishihara

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 31, 2012
Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancerPaul Lochhead, Yu Imamura, Teppei Morikawa, et al.
Journal of the National Cancer Institute|July 24, 2013
Microsatellite instability and BRAF mutation testing in colorectal cancer prognosticationPaul Lochhead, Aya Kuchiba, Yu Imamura, et al.
Journal for Immunotherapy of Cancer|October 6, 2020
Plasma IL-6 changes correlate to PD-1 inhibitor responses in NSCLCAlissa Keegan, Biagio Ricciuti, Padric Garden, et al.
Gut|February 14, 2018
Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicineShuji Ogino, Jonathan A Nowak, Tsuyoshi Hamada, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 12, 2013
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and diseaseShuji Ogino, Paul Lochhead, Andrew T Chan, et al.
Science Translational Medicine|April 25, 2014
Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD)Stephen P Fink, Mai Yamauchi, Reiko Nishihara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2012
Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancersYu Imamura, Teppei Morikawa, Xiaoyun Liao, et al.
NPJ Precision Oncology|March 20, 2018
Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncologyShuji Ogino, Iny Jhun, Douglas A Mata, et al.
Annals of Surgical Oncology|December 23, 2011
Prognostic significance and molecular associations of tumor growth pattern in colorectal cancerTeppei Morikawa, Aya Kuchiba, Zhi Rong Qian, et al.
Gut|March 20, 2012
Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectumMai Yamauchi, Teppei Morikawa, Aya Kuchiba, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|July 31, 2012
Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancerPaul Lochhead, Yu Imamura, Teppei Morikawa, et al.
Journal of the National Cancer Institute|July 24, 2013
Microsatellite instability and BRAF mutation testing in colorectal cancer prognosticationPaul Lochhead, Aya Kuchiba, Yu Imamura, et al.
Journal for Immunotherapy of Cancer|October 6, 2020
Plasma IL-6 changes correlate to PD-1 inhibitor responses in NSCLCAlissa Keegan, Biagio Ricciuti, Padric Garden, et al.
Gut|February 14, 2018
Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicineShuji Ogino, Jonathan A Nowak, Tsuyoshi Hamada, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 12, 2013
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and diseaseShuji Ogino, Paul Lochhead, Andrew T Chan, et al.
Science Translational Medicine|April 25, 2014
Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD)Stephen P Fink, Mai Yamauchi, Reiko Nishihara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2012
Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancersYu Imamura, Teppei Morikawa, Xiaoyun Liao, et al.
NPJ Precision Oncology|March 20, 2018
Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncologyShuji Ogino, Iny Jhun, Douglas A Mata, et al.
Annals of Surgical Oncology|December 23, 2011
Prognostic significance and molecular associations of tumor growth pattern in colorectal cancerTeppei Morikawa, Aya Kuchiba, Zhi Rong Qian, et al.
Gut|March 20, 2012
Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectumMai Yamauchi, Teppei Morikawa, Aya Kuchiba, et al.
Pageof 14